Mesenteric ischemia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Feham Tariq (talk | contribs) No edit summary |
Feham Tariq (talk | contribs) |
||
| Line 13: | Line 13: | ||
* All patients at risk of developing [[mesenteric ischemia]], should be educated about the signs and symptoms of the disease. | * All patients at risk of developing [[mesenteric ischemia]], should be educated about the signs and symptoms of the disease. | ||
* Patients who undergo [[Endovascular|endovascular repair]] for mesenteric ischemia should be recommended the following: | * Patients who undergo [[Endovascular|endovascular repair]] for mesenteric ischemia should be recommended the following: | ||
** Lifelong [[aspirin]] therapy | ** Lifelong [[aspirin]] and [[statin]] therapy | ||
** [[Clopidogrel]] for 1-3 months after the procedure | ** [[Clopidogrel]] for 1-3 months after the procedure | ||
** Lifelong [[Anticoagulant|oral anticoagulants]] in case of persistent atrial fibrillation, mesenetric venous thrombosis and inherited or acquired thrombophilias. | ** Lifelong [[Anticoagulant|oral anticoagulants]] in case of persistent atrial fibrillation, mesenetric venous thrombosis and inherited or acquired thrombophilias. | ||
Revision as of 19:55, 18 December 2017
|
Mesenteric ischemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mesenteric ischemia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Mesenteric ischemia secondary prevention |
|
Risk calculators and risk factors for Mesenteric ischemia secondary prevention |
Overview
Effective measures to prevent recurrence of mesenteric ischemia include screening by duplex ultrasonography, nutritional and life style modification, and drug therapy.
Secondary Prevention
The secondary prevention of mesenteric ischemia is similar to its primary prevention.
Effective measures for the secondary prevention of mesenteric ischemia includes the following:
- In patients with history of mesenteric ischemia, duplex ultrasonography is recommended after every 6 months for one year, and yearly thereafter.
- All patients at risk of developing mesenteric ischemia, should be educated about the signs and symptoms of the disease.
- Patients who undergo endovascular repair for mesenteric ischemia should be recommended the following:
- Lifelong aspirin and statin therapy
- Clopidogrel for 1-3 months after the procedure
- Lifelong oral anticoagulants in case of persistent atrial fibrillation, mesenetric venous thrombosis and inherited or acquired thrombophilias.
- Nutritional status and body weight should be monitored